CAPITOL HILL CONSULTING GROUP for ASTELLAS PHARMA US
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues pertaining to antimicrobial resistance; community and health care associated infections and organ transplantation; STARR Act
Foreign entity interest: Astellas Pharma, Inc., based in Tokyo, Japan, the owner of Astellas Pharma US as identified in its LD-1, has an interest in each issue on which Astellas Pharma US lobbies and would benefit from the specific desired outcome in the matters described above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Medicare/Medicaid MMM
Issues related to Medicare coverage of immunosuppressants
Foreign entity interest: Astellas Pharma, Inc., based in Tokyo, Japan, the owner of Astellas Pharma US as identified in its LD-1, has an interest in each issue on which Astellas Pharma US lobbies and would benefit from the specific desired outcome in the matters described above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.